| 000 | 01619 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518013452.0 | ||
| 264 | 0 | _c20190625 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1938-0690 | ||
| 024 | 7 |
_a10.1016/j.cllc.2018.11.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRotow, Julia K | |
| 245 | 0 | 0 |
_aPathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation. _h[electronic resource] |
| 260 |
_bClinical lung cancer _c03 2019 |
||
| 300 |
_ae137-e141 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdiagnosis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCrizotinib _xtherapeutic use |
| 650 | 0 | 4 |
_aExons _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-met _xgenetics |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWoodard, Gavitt A | |
| 700 | 1 | _aUrisman, Anatoly | |
| 700 | 1 | _aMcCoach, Caroline E | |
| 700 | 1 | _aBivona, Trever G | |
| 700 | 1 | _aElicker, Brett M | |
| 700 | 1 | _aJablons, David M | |
| 700 | 1 | _aBlakely, Collin M | |
| 773 | 0 |
_tClinical lung cancer _gvol. 20 _gno. 2 _gp. e137-e141 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cllc.2018.11.003 _zAvailable from publisher's website |
| 999 |
_c29166591 _d29166591 |
||